Cause of death, by non-communicable diseases, ages 0-4, female in Gabon
Gabon: Cause of death, by non-communicable diseases, ages 0-4, female was 8.1% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 0-4, female in Gabon, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 0-4.
Analysis
The most recent figure for cause of death, by non-communicable diseases, ages 0-4, female in Gabon is 8.1%, measured in 2021.
The figure is up 7.0% on the previous year and up 25.6% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4, female in Gabon peaked at 8.1% in 2019 and was at its lowest, 4.7%, in 2000.
That places Gabon 159th out of 185 countries with data for 2021, putting it in the bottom quarter.
Cause of death, by non-communicable diseases, ages 0-4, female in Gabon, year by year
| Year | % of total female deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 4.7% | — |
| 2010 | 6.5% | +37.4% |
| 2015 | 7.3% | +13.0% |
| 2019 | 8.1% | +11.2% |
| 2020 | 7.6% | -6.6% |
| 2021 | 8.1% | +7.0% |
Gabon compared with similar countries
- Gabon's 8.1% is below the median for upper middle income countries, which is 31.9%, 25% of the median. (55 countries reporting)
- Gabon's 8.1% is above the median for Sub-Saharan Africa, which is 8.1%, 1.0× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 4.7% | 4.7% | 4.7% | 1 |
| 2010s | 7.3% | 6.5% | 8.1% | 3 |
| 2020s | 7.9% | 7.6% | 8.1% | 2 |
Countries ranked near Gabon
More health data for Gabon
- Un projection of annual infant deaths, annual growth rate -0.9749 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8193 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 750.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 711 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 5 (2025)
- Population ages 00-04, female, annual growth rate 0.2502 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0638 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.2743 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4, female in Gabon?
- Cause of death, by non-communicable diseases, ages 0-4, female in Gabon was 8.1% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4, female recorded in Gabon?
- The highest recorded value was 8.1% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4, female recorded in Gabon?
- The lowest recorded value was 4.7% in 2000.
- How does Gabon rank for cause of death, by non-communicable diseases, ages 0-4, female?
- Gabon ranks 159th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4, female rising or falling in Gabon?
- Over the last ten years it is up 25.6%. The long-run trend across the full record is rising.
- Where does this Gabon data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.